Mr. Reali resigned April 4, and Anthony Bihl was appointed interim CEO, according to an April 3 SEC filing from Bioventus. Mr. Bihl has more than 35 years of experience in the medtech industry, according to an April 5 company news release.
Bioventus is currently seeking a permanent CEO. Mr. Reali’s departure comes just over a month after the company said its $450 million acquisition of CartiHeal may not happen.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
